Literature DB >> 11585373

Meningioma metastatic to thyroid gland.

R Hasan1, M C Marshall, M Medhi, A Arshad, A Braun, E Panageas.   

Abstract

OBJECTIVE: To describe the first reported case of meningioma metastasizing to and completely infiltrating the thyroid gland.
METHODS: We present a detailed case report, including radiographic, histologic, and immunostaining findings, in a patient with an atypical meningioma who had a progressively enlarging thyroid mass that proved to be a metastatic meningioma.
RESULTS: A 49-year-old man had a meningioma in the parieto-occipital region that had spread locally to the scalp and bone by the time of surgical resection. Local recurrence during the following year prompted repeated surgical resection, tumor embolization, radiotherapy, and chemotherapy. Despite aggressive therapy, the tumor progressed. A thyroid mass was first noted 2 years after the meningioma was diagnosed. Enlargement of the mass caused airway obstruction, necessitating an emergency thyroidectomy. Histologic examination of the thyroidectomy specimen showed that the thyroid gland had been extensively replaced by metastatic meningioma.
CONCLUSION: To our knowledge, this is the first reported case of metastatic meningioma extensively infiltrating the thyroid gland. This case report expands the spectrum of tumors that metastasize to the thyroid gland.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11585373     DOI: 10.4158/EP.7.5.370

Source DB:  PubMed          Journal:  Endocr Pract        ISSN: 1530-891X            Impact factor:   3.443


  2 in total

1.  Meningioma-like tumor of the thyroid: a previously undescribed variant of follicular adenoma.

Authors:  Gaetano Magro; Kamila Benkova; Michal Michal
Journal:  Virchows Arch       Date:  2005-05-13       Impact factor: 4.064

2.  Acute airway failure secondary to thyroid metastasis from renal carcinoma.

Authors:  Mario Testini; Germana Lissidini; Angela Gurrado; Gaetano Lastilla; Amato Stabile Ianora; Raffaele Fiorella
Journal:  World J Surg Oncol       Date:  2008-02-05       Impact factor: 2.754

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.